These actions could postpone NIH-funded clinical trials and create cash flow issues for domestic biotech companies.

In the last few days of the Biden Administration, the U.S. Department of Commerce’s Bureau of Industry and Security (BIS) issued a flurry of ...

On its way out the door, the Biden administration took a parting shot at America's most innovative companies in a ...

China’s much-vaunted C919 aircraft, produced by the state-owned Commercial Aircraft Corporation of China [Comac], relies on US firm GE Aerospace as a key stakeholder of the passenger jet’s engines. GE ...

President Trump has inherited an evolving chemical and biological threat landscape, but not one he hasn’t encountered before. Trump struck Bashar al-Assad’s airbases in 2017 and 2018, after the ...

The tariffs set by China will take effect on February 10. China’s Ministry of Commerce and Customs Administration also ...

The hiring freeze, imposed by President Donald Trump on Tuesday, affects all federal government agencies, but the restrictions ... the effects on medical and biotechnology research.

Deregulating New Zealand's gene tech space has been long-desired, but critics say the Government's growth-focused approach ...

Comprehensive restrictions target advanced technology ... semiconductors, and biotechnology. While the US has historically maintained technological superiority to preserve its dominance, China's ...

Chinese military officials have also publicly acknowledged biotechnology’s potential ... PLA medical institutions in China if regulatory restrictions are implemented,” the letter states.

A temporary freeze on meetings on the National Institutes of Health could lead to delays in disbursing research grants and in approving crucial clinical trials.

The Wuhan company didn’t bother with the dark web. It spruiked its goods right in the open, showing mounds of white powder ...